This compound is a highly specific chiral bis(oxazoline) ligand with a rigid, fused indeno[1,2-d]oxazole framework and defined (3aS,3'aS,8aR,8'aR) stereochemistry. It is primarily employed as a key ligand in the development and application of chiral catalysts for asymmetric synthesis, particularly in pharmaceutical manufacturing where high enantioselectivity (≥99% e.e.) is required for producing enantiomerically pure drugs. Its unique structure enables stereocontrol in reactions such as enantioselective hydrogenations, allylations, and other C-C bond formations. Available at ≥98% purity, it is a niche specialty chemical for advanced organic synthesis.